Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

SRPT — Sarepta Therapeutics, Inc. Dilution Risk Tracker

Track SRPT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SRPT — Get alerts when the score changes →

As of October 13, 2026, Sarepta Therapeutics, Inc. (SRPT) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Sarepta Therapeutics, Inc. has a market capitalization of $1.84B, 105.63M shares outstanding, 344 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 34%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 30% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track SRPT — Get forecast alerts →

Market Data

Market Cap$1.84B
Shares Outstanding105.63M
Float94.80M
Cash$788.49M
Debt$1.45M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding105.63MVerified float table or market cache
Public Float94.80MVerified float table or market cache
Market Cap$1.84BMarket data cache
Cash Runway7.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 21.9% shares (2026Q1 vs prior)
344 institutional holders · 127.57M shares
#1 BlackRock, Inc. 14.76M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 9.16M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 6.64M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest22.78M
Days to Cover8.6
% of Float24.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SRPT Dilution Snapshot

Sarepta Therapeutics, Inc. (SRPT) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SRPT's DilutionScore is currently 52/100 (High risk), with 5 score changes tracked over 89 days. The score improved from 48/100 (Medium risk).

Period Score Risk Level Duration
Oct 12 – Oct 13, 202652/100HIGH2 days
Oct 09 – Oct 11, 202648/100MEDIUM3 days
Aug 19 – Oct 08, 202652/100HIGH51 days
Aug 14 – Aug 18, 202644/100MEDIUM4 days
Jul 17 – Aug 13, 202653/100HIGH28 days
Jul 16, 202652/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SRPT shares outstanding have increased 0.8% from 104.79M (Mar 2026) to 105.58M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 22, 2026105.58M94.80M▲ 1.43%
May 09, 2026105.58M93.47M▲ 0.56%
May 04, 2026105.57M92.95M▲ 0.07%
Apr 28, 2026105.57M92.88M▲ 1.20%
Mar 05, 2026104.79M91.77M▲ 0.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SRPT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SRPT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SRPT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SRPT
SRPT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.